Holen Sie sich die Stockscreener-App
5.39
3.06%
-0.17
Schlusskurs vom Vortag:
$5.56
Offen:
$5.56
24-Stunden-Volumen:
660.92K
Relative Volume:
0.65
Marktkapitalisierung:
$322.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.80M
KGV:
-7.1867
EPS:
-0.75
Netto-Cashflow:
$-30.67M
1W Leistung:
-3.06%
1M Leistung:
+0.56%
6M Leistung:
-22.78%
1J Leistung:
-12.92%
1-Tages-Spanne:
$5.375
$5.62
1-Wochen-Bereich:
$5.375
$5.875
52-Wochen-Spanne:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Firmenname
Aldeyra Therapeutics Inc
Sektor
Branche
Telefon
781-761-4904
Adresse
131 HARTWELL AVENUE, LEXINGTON, MA
Vergleichen Sie ALDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
5.39 | 332.65M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-04-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-02-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-10-30 | Eingeleitet | Jefferies | Buy |
| 2020-10-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-22 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-05-12 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-04 | Eingeleitet | Citigroup | Buy |
| 2018-09-26 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Janney | Buy |
| 2018-01-26 | Eingeleitet | Seaport Global Securities | Buy |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-07-01 | Eingeleitet | Stifel | Buy |
| 2015-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2015-03-20 | Bestätigt | H.C. Wainwright | Buy |
| 2014-11-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-06-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap - Quantisnow
Proliferative vitreoretinopathy Pipeline Analysis & Clinical Trials, 2025, DelveInsight | Aldeyra Therapeutics, Tetra Bio-Pharma, Aviceda Therapeutics - The Globe and Mail
Published on: 2025-09-08 19:00:28 - beatles.ru
Is Aldeyra Therapeutics Inc. benefiting from interest rate changesWeekly Profit Analysis & Short-Term High Return Ideas - beatles.ru
ADAR1 Capital Management LLC Has $1.22 Million Position in Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Advanced analytics toolkit walkthrough for Aldeyra Therapeutics Inc.Market Activity Report & Low Risk Growth Stock Ideas - Newser
How to integrate Aldeyra Therapeutics Inc. into portfolio analysis toolsWeekly Loss Report & Community Driven Trade Alerts - Newser
Is Aldeyra Therapeutics Inc. a candidate for recovery play2025 Analyst Calls & Weekly Top Gainers Alerts - Newser
Earnings Recap: What is the long term forecast for Aldeyra Therapeutics Inc. stock2025 Risk Factors & Daily Volume Surge Signals - خودرو بانک
Wellington Management Group LLP Invests $675,000 in Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Momentum divergence signals in Aldeyra Therapeutics Inc. chartQuarterly Profit Report & Weekly High Conviction Ideas - Newser
Will Aldeyra Therapeutics Inc. outperform the marketJuly 2025 EndofMonth & Real-Time Volume Triggers - Newser
Does Aldeyra Therapeutics Inc. have strong fundamentalsCPI Data & AI Based Buy and Sell Signals - خودرو بانک
News impact scoring models applied to Aldeyra Therapeutics Inc.2025 Earnings Impact & Daily Market Momentum Tracking - Newser
Aldeyra Therapeutics (ALDX) Stock Price, News & Analysis - MarketBeat
Sector ETF performance correlation with Aldeyra Therapeutics Inc.Market Risk Analysis & Consistent Profit Trading Strategies - Newser
Historical volatility pattern of Aldeyra Therapeutics Inc. visualizedQuarterly Market Review & High Return Trade Opportunity Guides - Newser
What technical models suggest about Aldeyra Therapeutics Inc.’s comebackWeekly Profit Report & Daily Chart Pattern Signals - Newser
Best data tools to analyze Aldeyra Therapeutics Inc. stock2025 Analyst Calls & Low Risk High Reward Ideas - Newser
How moving averages guide Aldeyra Therapeutics Inc. tradingRisk Management & Precise Buy Zone Tips - Newser
Is Aldeyra Therapeutics Inc. building a consolidation baseMarket Performance Report & AI Based Trade Execution Alerts - Newser
Can trapped investors hope for a rebound in Aldeyra Therapeutics Inc.Oil Prices & High Yield Stock Recommendations - Newser
Aldeyra granted fast track designation for ADX-2191 by FDA - MSN
Market reaction to Aldeyra Therapeutics Inc.’s recent newsMarket Movement Recap & AI Based Buy and Sell Signals - Newser
Can Aldeyra Therapeutics Inc. deliver consistent dividendsJuly 2025 Momentum & AI Based Buy and Sell Signals - خودرو بانک
Comparing Aldeyra Therapeutics Inc. in custom built stock radars2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Using economic indicators to assess Aldeyra Therapeutics Inc. potentialWeekly Trade Recap & Reliable Breakout Stock Forecasts - Newser
Is Aldeyra Therapeutics Inc. stock bottoming outAnalyst Downgrade & Expert Curated Trade Ideas - Newser
Kingdon Capital Management L.L.C. Takes $4.48 Million Position in Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Full technical analysis of Aldeyra Therapeutics Inc. stockBear Alert & Detailed Earnings Play Strategies - Newser
Aldeyra Therapeutics Inc. stock trendline breakdownEarnings Miss & High Conviction Buy Zone Alerts - Newser
Can Aldeyra Therapeutics Inc. generate free cash flowInsider Buying & Community Verified Trade Signals - خودرو بانک
Using fundamentals and technicals on Aldeyra Therapeutics Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Aldeyra Therapeutics: A High-Potential Biotech Play in Immune-Mediated and Ophthalmic Diseases - AInvest
Tech Rally: Is Aldeyra Therapeutics Inc. stock forming a cup and handleTrade Risk Summary & High Return Stock Watch Alerts - خودرو بانک
Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
Real time scanner hits for Aldeyra Therapeutics Inc. explainedBreakout Watch & Daily Stock Trend Watchlist - Newser
Ranking Aldeyra Therapeutics Inc. among high performing stocks via tools2025 Price Momentum & Risk Managed Trade Strategies - Newser
Can Aldeyra Therapeutics Inc. expand its profit margins2025 Earnings Impact & Free High Return Stock Watch Alerts - خودرو بانک
Earnings visualization tools for Aldeyra Therapeutics Inc.Market Performance Report & Long-Term Capital Growth Ideas - Newser
What dividend growth rate does Aldeyra Therapeutics Inc. offer2025 Investor Takeaways & Technical Pattern Alert System - خودرو بانک
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):